Chronic obstructive pulmonary disease, inflammation and co-morbidity - A common inflammatory phenotype?

219Citations
Citations of this article
111Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is and will remain a major cause of morbidity and mortality worldwide. The severity of airflow obstruction is known to relate to overall health status and mortality. However, even allowing for common aetiological factors, a link has been identified between COPD and other systemic diseases such as cardiovascular disease, diabetes and osteoporosis. COPD is known to be an inflammatory condition and neutrophil elastase has long been considered a significant mediator of the disease. Pro-inflammatory cytokines, in particular TNF-α (Tumour Necrosis Factor alpha), may be the driving force behind the disease process. However, the roles of inflammation and these pro-inflammatory cytokines may extend beyond the lungs and play a part in the systemic effects of the disease and associated co-morbidities. This article describes the mechanisms involved and proposes a common inflammatory TNF-α phenotype that may, in part, account for the associations. © 2006 Sevenoaks and Stockley; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Sevenoaks, M. J., & Stockley, R. A. (2006, May 2). Chronic obstructive pulmonary disease, inflammation and co-morbidity - A common inflammatory phenotype? Respiratory Research. https://doi.org/10.1186/1465-9921-7-70

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free